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Abstract
Objective: To construct a comprehensive vaccine information ontology that can support personal health
information applications using patient-consumer lexicon, and lead to outcomes that can improve patient education.
Methods: The authors composed the Vaccine Information Statement Ontology (VISO) using the web ontology
language (OWL). We started with 6 Vaccine Information Statement (VIS) documents collected from the Centers for
Disease Control and Prevention (CDC) website. Important and relevant selections from the documents were recorded,
and knowledge triples were derived. Based on the collection of knowledge triples, the meta-level formalization of the
vaccine information domain was developed. Relevant instances and their relationships were created to represent
vaccine domain knowledge
Results: The initial iteration of the VISO was realized, based on the 6 Vaccine Information Statements and coded into
OWL2 with Protégé. The ontology consisted of 132 concepts (classes and subclasses) with 33 types of relationships
between the concepts. The total number of instances from classes totaled at 460, along with 429 knowledge triples in
total. Semiotic-based metric scoring was applied to evaluate quality of the ontology.
Keywords: Biomedical informatics, Vaccines, Vaccine Information Statements, Knowledge based systems, Ontology,
Ontology construction
Introduction
In the present information age, patients are affordedmany
options to educate themselves on vaccines. Some of these
options included valid and reputable websites, books, and
other media sources while other options may appear rep-
utable but are not. Regardless of the source’s credibility,
one researcher found that 70% of individuals who seek
vaccine information online are influenced by what they
find on the Internet [1]. Hopefully, patients and parents
are able to identify the most reliable resources such as
the Centers for Disease Control and Prevention’s (CDC)
Vaccine Information Statements (VIS). VISs were devel-
oped in response to the National Childhood Vaccine
Injury Act (NCVIA) which was passed in an effort to
minimize provider liability and respond to public health
concerns. The NCVIA requires healthcare providers to
provide a VIS to the person receiving the vaccine or
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his/her guardian. The VIS must be given each time a
vaccine is administered and provides information on the
benefits and risks of the vaccine as well as other rele-
vant disease information. They are usually provided to the
patient as a handout [2].
Some researchers have identified specific issues with
the dissemination of vaccine information through these
documents. Both Lieu, et al., and St. Amour, et al. have
revealed that vaccine documentation handed to patients
are rarely read or fully understood by the patient [3,4].
This kind of education is called passive education, because
the patients may or may not choose to read the materials.
In addition, while the purpose of the VIS is to inform par-
ents and initiate potential questions, limited clinical staff
time and resources may hinder the optimal interactions
ideal for vaccine education. This demonstrates a pervasive
issue with medical education for patients, where the deliv-
ery and presentation should bemore consumer-friendly in
order to effectively impact patient education and increase
knowledge [5-7].
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Biomedical-related ontologies have had an impact on
patient learning and decision-making by utilizing patient-
friendly terminology rather than confusing medical jar-
gon. Ontologies are understood to be a consensus-based
controlled vocabulary between terms and relationships,
while serving as a vehicle of interaction between humans
and computers. In lay terms, it is similar to concept
maps or graphs but with the capacity to link with other
graphs, and evoke reasoning and inferences. Some pub-
lished examples and ideas include:
• ontology-driven clinical decision support systems
for patients in regards to discharge medication [8],
• building medical ontology models for Italian
patients [9],
• an ontology-based coaching tool for physicians to
prepare dialogue with patients [10],
• and dialogue systems for patient planning [11]
Following in the examples described, we developed an
ontology-driven mobile application system to improve
patient learning and comprehension of vaccine knowl-
edge [12]. While a proof of concept prototype, the sys-
tem was limited by the test ontology which comprised
of 19 classes and 82 instances, a relatively small knowl-
edge base with which to interact. To further extend
this project, as a first step, we aimed to create a com-
prehensive vaccine ontology with which patients can
interact.
The objective of this paper is to formalize the vac-
cine knowledge for patient education using ontology tools
as a solution for vaccine education for the public. We
propose modeling vaccine knowledge using OWL2 (Web
Ontology Language) [13], which will be encoded with
Protégé [14]. We focus on the knowledge in the VISs
developed by the CDC. By publishing the Vaccine Infor-
mation Statement Ontology (VISO) in a domain ontology
and offering the benefit of a serialized format that can
be processed by a machine and reused [15], we intro-
duce opportunities to develop ontology-driven personal
health agents to improve patient learning and compre-
hension of vaccine knowledge. Overall, the overarching
goal is to develop a scalable ontological model that can
reliably cover any new and applicable vaccine knowledge
for a consumer audience. With a scalable conceptual-
level model, opportunities in natural language ontology
learning and population would be a future possibility to
investigate for automated upkeep and maintenance of the
ontology.
This paper will start by briefly discussing the source
material, the VISs. Afterwards, the paper will segue way
into describing the development of the class-level schema
and the instance level of VISO. This will include discus-
sion of the initial common design patterns encountered
and basic ontology metrics. The Results section will elab-
orate the quantitative and qualitative aspects of VISO, that
also includes an initial evaluation scoring. The paper will
then close with challenges in developing an ontology from
the CDC VISs and future direction.
Materials
The focus of this paper is the ontology representation of
the knowledge in the VISs developed by the CDC. Cur-
rently there are 25 VISs available from the CDC’s website,
and these documents vary between 1 to 2 pages [16].
The VISs describe patient-level information about vac-
cines ranging from the historical burden of disease to the
clinical indications for the vaccine.
The current iteration of the VISO is derived from six
CDC VISs:
• Diphtheria, tetanus, and acellular pertussis vaccine
(DTaP) [17]
• Rotavirus vaccine [18]
• Hepatitis B vaccine [19]
• Haemophilus influenzae type B vaccine (Hib) [20]
• Measles, mumps, and rubella (MMR) [21]
• Pneumococcal conjugate vaccine (PCV13) [22]
All of the vaccines selected are recommended for chil-
dren on or before the first year of life. Each of the VIS
documents are available for download from the CDC’s
website in both PDF and RTF format, along with the
HTML version.
The VISs are written at a 10th grade reading level [23],
and with no images or figures to supplement any passages.
Also from a subjective observation, there appears to be
some organized consistency of the content within each of
the documents, which also helped provide a skeletal struc-
ture for the VISO ontology. Some examples of consistent
dedicated sections included:
• General vaccine and disease information.
• Possible vaccine reactions and/or side effects.
• Populations for whom the vaccine is indicated.
• General vaccine recommendations and dose
information.
Method
Each of the six VISs acquired from the CDC’s website
were examined, and sentences were identified as relevant
selections to inform the design of VISO. Ignoring headers
and standard text that appeared on VIS documents, the
relevant passages were transcribed onto a tracking spread-
sheet and coded for simple identification. Any fragment
with bullet points was also recorded. Each phrase in the
VIS was broken down into a knowledge triple, which is
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a piece of factual information that is decomposed to a
subject-predicate-object format that can be visually rep-
resented or modeled in an ontology. Separate tracking
documents were used for individual VIS documents for
management purposes. Later, separate knowledge mod-
els for each of the VIS documents were realized, and
then collated to obtain a comprehensive model of vaccine
information. The proceeding subsections will discuss the
high-level conceptualization of the VISO model, detailing
the class-level organization and formalization of knowl-
edge, and the last subsection will discuss the encoding of
the instances and triples, along with reoccurring design
patterns in the VIS domain. The end goal was to develop
common classes that can accommodate a large corpus
of vaccine information, and have a formalized model to
cover an expansive vaccine domain that is relevant for
patients.
Meta-level conceptualization
For a presentation of the properties between the classes
see Figure 1. The oval shapes in the diagram depicts
the high-level classes in VISO. Between the oval-shaped
classes, a line connects two classes to signify a relation-
ship, and a dotted line depicts a relationship between
subclasses. Labels are placed beside both the classes
and the relationship connection to provide identification.
For clarification, some classes in the diagram have the
same name, which means they are referring to the same
class.
Class-level representation
Figure 1 illustrates the meta-level interpretation of the
VISO. The model represents a composite of the high
abstraction understanding of the six VISs with 23 unique
high-level parent classes. Table 1 outlines all of the high-
level classes employed for the six VIS document models.
The first column lists the formal name of the high-level
class, and its corresponding description is listed in the
next column. Also, examples of subclasses derived from
the class and sample instances are listed in another col-
umn, and a count of the number of instances using the
class (or using its subclasses) were registered. The most
salient classes found in all of the VIS documents wereVac-
cine, Target, Reaction, Dosage, and People. The Vaccine
class designated the vaccine that is the subject of the VIS
document. Target class referred to what the Vaccine class
is protecting against, e.g. hepatitis B, rotavirus, etc. The
Reaction class categorizes any possible side effect or reac-
tion following vaccination. The Dosage class is used for
any vaccine series and/or dose information from the VIS,
Figure 1 Vaccine Information Statement Ontology (VISO). Parent-level graph of VISO classes.
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Table 1 Class table
Meta-level class Description Example subclasses or Instances (in italics) Instances
Vaccine A class description to categorize vaccines
documented by the CDC’s VIS documentation
AlternateVaccine 9
Target Provides class specification for virus, bacteria,
diseases, etc. that are prevented by Vaccine
Disease
Virus, SeriousDisease, Bacteria 12
People Categorizes various types of patients or groups of
individuals impacted by vaccines, diseases,





Source Used to describe an origin of a vaccine’s target
(bacteria, disease). Can be reused in relations with
other classes.
bacteria, Hepatitis B virus 5




Cause For a description of a condition as a result of a
vaccine target. E.g. infection, coughing spells.
ear infection, long-term illness, coughing spells, pneumonia 39
Location Type to categorize location, specifically area of the
body, affected by a heath condition or reaction
FacialLocation, ThroatLocation, ArmLocation 14
Probability Classification for types of probabilities




Outcome Types of effects resulting from causation,




Duration Used for various types of descriptions for
qualitative length of time for effects of health
conditions or signs of conditions.
DurationInMinutes, DurationInWeeks 5
Substance Classification of kinds of substance for vaccines




Combination For various artifacts that interact with vaccines. SafeCombination, DangerousCombination 1
Method Groups and classifies inoculation methods for
vaccines.
InhaleMethod, InjectionMethod, OralMethod 1
NumberOfDoses Enumerates the maximum number of doses for
vaccine.
OptionalNumberOfDoses 6
Dosage Designates the types of dose or the dose interval.
E.g. 1st Dose, 3rd Dose.
OptionalDose, DoseIntervals 23
Component Categorizes types of elements of a vaccine. ViralComponent, NoninfectiousViralComponent 3
Age Enumerates the type of quantitative classification
of age ? years, months, weeks, etc.
AgeInMonths, AgeInYears 25
Date Enumerates the types of quantitative classification
of date ? days, months, weeks, etc.
DateInYears, DateInMonths, DateInDays 4
Occurrence Classification of types of events VaccinatedOccurence, TimedOccurence 24
Action Types of patient recourse in response to
reactions or actions required vaccine patients
before inoculation.
InactiveAction, ActiveAction, EmergencyAction 8
Allergen For classes of substances leading to an allergic
reaction.
VaccineAllergen, VaccineComponentAllergen 7





Sign Class of indicators for vaccine reaction effects. fast heartbeat, crying, stomach pain, hives 14
Total instances of classes 460
and the People class organizes various classes of patients
who may or may not be recommended to receive the
vaccine.
Subclass-level representation
The VISO model’s high-level classes utilizes extensive
subclassing to cover specific abstraction of entities. One
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apparent use was for categorization purposes to organize
the knowledge for better identification, such as the case
for the People class. For example, the VIS documents often
refer to a specific population that may react differently to
vaccines, or may need a different vaccine type due to age
or certainmedical conditions, justifying the need to create
subclasses to refer to specific groups of people.
Another motivation for subclasses is to facilitate
descriptions from the text that are in the form of
adjectives or prepositions. If the documentation refers
to the number of optional doses of a vaccine, a sub-
class called OptionalNumberOfDoses, which is a child
of NumberOfDoses, was defined. Attention was given
to classes that have “universal” subclasses that may not
have been observed from the VIS documentation. Some
examples are Organ class (“Heart”, “Liver”, “Lungs”) or
Substance class (“GaseousSubstance”, “LiquidSubstance”,
“SolidSubstance”).
Value sets and partitions
To address quantitative, descriptive, or ranks in classes,
value set representations, as described in a W3C work-
ing draft [24], was utilized for the VISO meta-ontology.
More specifically, we use subclasses to represent per-
missible values in a value set. For example, the VIS
documentation alluded to a three-point scale, especially
when describing severity of conditions - mild, moder-
ate, severe (or serious). We created a Reaction class that
has the subclasses MildReaction, ModerateReaction, and
SeriousReaction to describe the degree of vaccine effect
severity. Other classes that employ value sets include
the People class and the Target class. For any other
units of measure revealed in the VIS documents, spe-
cific classes yielded subclasses that handled units of
measure, such as, AgeInYears and AgeInMonths for the
Age class or DateInMonths and DateInDays for the Date
class.
Properties
Knowledge triples evoked by the VIS documents sug-
gested common relationships or properties between
classes across the VIS corpus. In all of the 6 documents,
it was common to describe a vaccine preventing a bacte-
rial infection or virus, or a vaccine can potentially cause
a rare reaction following administration. Many of these
properties between the classes were identified and nor-
malized to a standard representation. One example in the
DTaP VIS, the evoked triple - “Another vaccine, called Td,
protects against tetanus and diphtheria...” - utilized the
predicate “protect against”, which essentially means “Td
prevents tetanus and diphtheria”. In result, “Td protects
against tetanus” was rendered as “Td prevents tetanus”,
where “prevents” is the standard property, or controlled
term, to describe that specific relationship.
Table 2 identifies all of the object properties utilized in
VISO. The first column list the domain classes, with the
properties and range classes in the subsequent columns.
Overall, 33 types of object properties exist in the current
iteration of VISO.
Table 3 list data properties. Similar in format to Table 2,
two types of data properties are used in VISO with the
domain listed as Protégé’s superclass Thing and a string
literal for its range. These data properties are meant to be
global to all of the classes. These two properties serve as
utility properties to accommodate information that either
provide an alternative name ( “also known as”) or infor-
mation that describe or define an object of the class ( “is
described as”).
Instances and triples
Afterwards, the meta-level ontology development led into
the encoding of instances from the collected VISs. Refer-
ring to Table 1, the People class accounted for most of
instances, with 93 instances of the People classes. Since the
initial set of VIS documents was small, some of the classes
had one instance stemming from its class. There is a pos-
sibility that the remaining VIS documents may add more
instances to these classes.
Earlier, we indicated that across the VIS documents
there exist some consistency that influence the represen-
tation of knowledge in the VISO. This was also reflected
in how the instances are conceptualized. The following
subsections list some noticeable design patterns observed
in the development of VISO - dosage pattern for vaccine
dose representation, target pattern for representing the
object of vaccine prevention, and the reaction pattern for
possible side effects of the vaccine.
Dosage pattern
Every vaccine documentation outlines the number of
doses, and when and who should receive the vaccine.
The three knowledge triples provided in the representa-
tion in Figure 2, where statement 1 is represented as a
ChildDose subclass, and their corresponding dose order
(statements 2 and 3) are depicted in subclasses of Age for
the the time of the vaccination. Most of the dose informa-
tion found in the VIS documents are modeled similarly in
VISO.
Target pattern
Pertinent information on what a vaccine protects against
is found in the six vaccine statements. Target instances
comprise of measles, tetanus, pneumococcal disease,
rotavirus, pertussis, etc. Figure 3 illustrates a typical
pattern forTarget instances. In the figure, the 9 statements
listed aremapped in accordance to the VISOmodel. State-
ment 1 reveals the type of Target (“Serious Disease”) that
diphtheria is. Statement 2 is abstracted with a Source
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Table 2 Object properties
Domain Properties Range Triples
Target, Cause, Reaction affects People, Location 11
Dosage after Date 2
PeopleWithAllergicReaction, AllergicReaction allergic to Allergen 7
Dosage before Occurrence 1
PeopleBornFrom born from Date 1
Target causes Cause 40
Vaccine contains Component 3
Vaccine discouraged for People 19
NumberOfDoses for People 5
Cause, Outcome, Reaction happens Probability 42
Vaccine has alternate Alternate Vaccine 4
Vaccine has dosage Dosage 26
Vaccine has number of NumberOfDoses 6
Reaction has signs Sign 14
Vaccine is a substance of Substance 1
Vaccine is safe for People 6
Vaccine is safe with Combination 1
Vaccine is taken Method 1
Target, Reaction, Sign, ObjectChannel lasts Duration 5
Target, Cause, Outcome, Reaction leads Outcome 31
Cause, Reaction located Location 15
Vaccine may cause Reaction 54
Reaction need Action 3
Reaction, Sign occurs after Date, Occurrence 24
PeopleOfAge of age Age 3
Target originates Source 5
Vaccine prevents Target 11
Vaccine protects People 23
Target spreads through Channel 19
People take Action 5
Dosage taken at Age 22
Cause to People 2
HumanActivityChannel with People 2
Total number of triples 414
Table 3 Data properties
Domain Properties Range Triples
Thing also known as string data 7
Thing is described as string data 8
Total number of triples 15
subclass of Bacteria, with a relationship of “originates”
with theTarget instance. Likewise, statement 3 is shown as
PeopleChannel subclass of Channel. Statements 5 through
9 are facilitated by the Cause class with relationships
to instances of Location and Outcome classes. This is
an example is indicative of how Target class instances
and their commonly related relationships are modeled in
VISO.
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Figure 2 Dosage modeling example. Example of Dosage instance representation with an excerpt from the MMR VIS.
Reaction pattern
Reaction patterns modeled possible reactions from vacci-
nations described in each of the VIS documents. Figure 4
shows a model of three sample statements. Statement 1
shown as an instance of Vaccine may cause MildReac-
tion triple. Statement 2 alludes to the left branch with an
instance of MildReaction located at Location, and state-
ment 3 represented in the right branch of a Probability
subclass of ProbabilityInPatients.
The patterns described in this section are the most
evident types in the mapping of the information, but addi-
tional vaccine information design patterns also exist. It is
also understood that more patterns may emerge with the
inclusion of the remaining VIS documents.
Quality evaluation
To evaluate the overall quality of VISO, the ontology
was scored using the ontology metrics suite proposed
by Burton-Jones, et al. [25]. Inspired by semiotics con-
cepts, this simple, yet extensive ontology scoring metric
evaluates an ontology based on four criteria - seman-
tic, syntactic, social, and pragmatic levels. The semantic
criteria evaluates the term meanings and word sense of
each of the terms. The syntactic criteria assesses syn-
tax of the ontology, while social criteria examines how
other ontologist use the ontology through links. The prag-
matic criteria evaluates the practicality of the ontology,
relating to its usage and its construction. Also, the evalu-
ation metric is flexible to allow individual tailoring if any
of the criteria does not apply, as demonstrated in refer-
ence [25]. The resulting final score is a value between 0
and 1.
Because of the initial design of the ontology, the scoring
metric needed to be tailored to provide a progress indica-
tor of its development. For example, social criteria which
is dependent on other ontologies linking to VISO was not
Figure 3 Target modeling example. Example of Target instance representation with an excerpt from the DTaP VIS.
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Figure 4 Reaction modeling example. Example of Reaction instance representation with an excerpt from the Hepatitis B VIS.
possible to determine, therefore, it was excluded from the
complete calculation score.
However, the attainment of the other scores were
straightforward. The semantic quality score (E in
equation (1)) was attained by a normalized summation
of “Interperatability” (w1 as terms with a word sense in
WordNet/TC as total terms used in the ontology), “Con-
sistency” (misused terms as i/total classes, properties, and
instances as C), and “Clarity” (average number of word
senses for each term, w2/total classes, properties, and
instances, C). For w1 (“Interperatability”) and w2 (“Clar-
ity”), a simple Java GUI-based application utilizing the
ws4j library for WordNet [26] and the OWL API libray
[27] was developed to automate and retrieve the values





















The pragmatic score, P, was determined by the normal-
ized summation of “Comprehensiveness” (C/500 as total
number of classes and properties over 500, the maxi-
mumnumber for classes and properties for the calculation
[25]), and “Accuracy” (false statements as f /total number
of statements from the ontology as TS). “Relevance” scor-
ing (application of statements/total number of statements)
involves ontology usage in an application, which was omit-
ted. For “Accuracy”, vaccine subject matter experts were
given a list of statements from the ontology and were
asked to label whether the statement was true or false and
to provide any corrections.While the terminology and the
knowledge source was primarily from the VIS, our vac-
cine experts also interact directly with patients and their
concerns relating to vaccines which helped to focus on
the patient-centric goal of the VIS. Below, equation (2)














For syntactic quality, S, the Protégé editor provided
some of the values for the scores. Both the “Lawful-
ness”, number of syntactic violations over total number of
statements in the ontology (l/TS) and “Richness”, num-
ber of syntactic elements utlized over the total syntactic
elements (s/SF) accounted for the normalized sum of syn-















While the metric evaluation can be tailored specific to
the ontology, aspects like the social criteria and “Rele-
vance” were excluded. The modified final score is repre-
















The VISOwas serialized in OWL2 with Protégé. Themet-
rics data collected from Protégé is shown in Table 4. The
first column displays the item and the second column
displays the value associated. The current VISO model
produced a class count of 132, including subclasses; 33
object properties; 2 data properties; and 419 unique indi-
vidual instances. In addition, 460 instances derived from
concepts were created, along with a total of 429 knowledge
triples.
Table 4 VISOmetrics data
Class count 132
Object property count 33
Data property count 2
Unique individual count 419
Instances asserted from classes 460
Total knowledge triples 429
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As stated earlier, part of the process in engineering the
abstraction of the VIS involved obtaining passages to be
mapped into the model. Table 5 displays the number of
passages parsed for evaluation under the “Total Passages”
column. Also, the third column recorded the number of
instance triples produced. For all six of the VIS document
sources, a total of 244 sentences and passages were used,
and 427 instance triples were extrapolated from them, and
later merged and coded with Protégé to VISO.
Table 2 indicate the number of knowledge triples
present in the current VISO version. Most of the triples
were mainly of the “Vaccine may cause Reaction” type,
with 54 instances of that triple. Total number of instances
of triples in VISO numbered at 429 (derived from Tables 2
and 3), that includes the 15 instances of triples denoted by
data property relationships from the table in Table 3.
Both the HermiT (version 1.3.8) and the FaCT+ reason-
ers with the Protégé editor did not reveal any discrepan-
cies with this version of the model.
The final quality score for evaluation, Q, based on the
tailored equation (4) calculated to 0.54. Observing the
other components of the quality score, the semantic qual-
ity, E, amounted to 0.59. Pragmatic quality and syntactic
quality equated to 0.75 (P) and 0.27 (S), respectively.
Result analysis
While the construction of VISO is in the early stages and
covering 6 VISs, the quality score appears to reflect the
early developmental state of the ontology. However, look-
ing at the decomposition of the score can reveal some
insight to VISO and possibly inform the future direction
of the VISO development.
Observing specifics of the semantic quality, the “Clarity”
component score (0.89) reveals less ambiguity among the
terms. The “Interpertability” value (0.74) also indicates
the use of meaningful terms in the ontology, and the
inconsistency of the terms was low (0.04).
With pragmatic quality (0.75) of VISO, we ignored the
“Relevance” quality due to unavailability for deployment in
an application environment. “Comprehensiveness” quality
(1.2) was exceedingly high due to being a large ontology
with many classes and properties. Based on reports from
Table 5 Extraction Results
CDC VIS Total passages Instances of triples in VISO







two expert reviewers, VISO’s inaccuracy was relatively
low at 0.30.
Syntactic quality revealed no violations with syntax,
however, the “Richness” quality computed at 0.54, reflect-
ing that VISOwas utilizing a little over half of the syntactic
features available.
Based on the results, the VISO’s strength lies in its prag-
matic quality which indicates its overall usability based
on the two of the three components described earlier -
“Accuracy” and “Comprehensiveness”. The excluded com-
ponent, “Relevance”, could provide a more holistic score
in the future. Syntactic outcome was the weakest of the
three aspects of VISO’s quality. This is partially due to
the minimal usage of ontology features available. Focus on
this aspect will warrant attention in future development of
VISO.
Relating to Consistency, some terms, according to
reviewers, were improperly used or required nuanced
descriptions. One example is the term “Dosage” which is
technically used to describemeasurement of a vaccine and
not a synonym for “dose”. Another example are property
labels like “cause”. Some instances in the ontology should
have been labeled “may cause” to imply a possible causa-
tion, rather than an expected outcome. Proper and precise
term usage will be another focus that the next version of
VISO will rectify.
Discussion
Modeling the CDC’s VISs posed several challenges. One
challenge was determining relevant pieces in the corpus
that could be used for knowledge extraction. Most of
the documents had statements that were either repetitive,
or had literary flourishes that were deemed unnecessary.
Also, the documents may have a paragraph or a sentence
that summarizes preceding information with granular-
ity. In most cases, these were viewed as repetitive, yet
may serve a future purpose if the ontology were to be
used to construct dialogue with patients. Additionally, the
documentation comprised of some knowledge that were
historical statements. An example from the rotavirus VIS:
Because children are protected by the vaccine,
hospitalizations, and emergency visits for rotavirus
have dropped dramatically. [18]
It is debatable whether the historical informationmay be
useful to patients, or if summarized statements, which are
naturally repetitious in these documents, could be inte-
grated into the VISOmodel. In this initial version of VISO
the repetitive and historical texts were not mapped but
may be considered in future versions of the ontology.
Another challenge were gaps in the knowledge where
the information was incomplete, brief, or needed med-
ical understanding beyond the lay person. Some of the
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language in the documents may not be readily evident to
a parent or patient, and would require a medical profes-
sional to provide interpretation. For example, if a certain
vaccine should not be given to a child who is “moderately
ill”, how does the reader of the VIS determine the exact
signs of a “moderately ill” child as opposed to a child who
may be “mildly ill”? If the documents refer to a sign as
“physical weakness”, how does the patient or the reader
determine features or indicators of “physical weakness”?
Issues like these limited the scope of the VISO knowledge-
base. In practice, the healthcare provider, rather than the
parent, will determine if the child is too ill to receive the
vaccine. It is the medical professional’s responsibility to
provide judgment and guidance to the patient. Similarly,
there were issues with limited number of VIS documents
to develop the VISO models and to create instances. Lack
of additional information resulted in some of the classes
not having any subclasses to suggest.
Expressing the knowledge contained within the VIS
documents posed some challenges as well. While the
meta-level definition was designed with subclasses to han-
dle descriptive instances, there are often passages with
complex nouns and adjectives where each word carried
important meaning for the instance. Examples such as
“painful tightening of muscles” or “difficult for infants to
breathe” posed a predicament of whether these instances
should be decomposed to additional classes and rela-
tionships; use a subclass or create a new subclass; apply
polymorphism; or keep as is as an instance. In most cases,
they were realized as a single instance, until the meta-
level model is further developed to map difficult passages.
Moreover, given the historical nature of the VISs and con-
sidering that several VISs were originally developed more
than 30 years ago in response to NCVIA, it is assumed
that subsequent versions contain much of the original
language. This likely contributes to the variability in the
semantic language of the ontology.
Conclusion and future direction
We introduce the Vaccine Information Statement Ontol-
ogy, which could positively influence the development of
intelligent ontology-drive applications and mitigate the
knowledge gap that often exists in patients seeking accu-
rate and reliable information but encountering complex or
inaccurate sources. Possible future goals in continuing the
development of the VISO include:
• Expand the Vaccine Information Statement Domain.
This version of the VISO models 6 VIS documents as
an initial iteration to examine the ontology. The next
few iterations of VISO will include more domain
knowledge from the remaining 19 VIS documents,
available from the CDC website. There is also an
awareness that additional knowledge can be modeled
from outside the CDC’s VIS documents. It is also
assumed that the meta-level design will mature as we
realize alternative interpretation of vaccine
information, or discover abstractions that could
integrate some of the ignored passages and phrase,
like negation statements or summary passages. With
an expanded version and throughout the
development cycle, we plan to evaluate the ontology
using semiotic-based metric suite, and also adapt the
suite to also include aspects previously excluded, like
social quality or Relevance.
• Link VISO with existing relevant ontologies to
expand the knowledge domain. Some third party
ontologies that could be aligned with the VISO may
include the Vaccine Ontology (VO) [28], Ontology of
Vaccine Adverse Effect (OVAE) [29] or Medical
Dictionary for Regulatory Activities (MedDRA) [30]
to address reaction or conditions in the VISO. This
approach would comprise of code-linking particular
classes with matching classes in the VISO model,
which would lead into providing a comprehensive
and expanded knowledge-base for patient learning.
However, because the knowledge-base is intended for
patient use, it will be essential to determine the
appropriate since the aforementioned third party
ontologies utilize professional vocabulary which may
not be understood by patients.
• Integrating patient-level synonymous terms and
multi-language equivalents into the lexicon. A
multi-lingual VISO would presumably expand to
reach potential patients who may be excluded
because of language or socio-economic barriers.
There is also an interest in using the Open Access,
Collaborative Consumer Health Vocabulary Initiative
[31] as a resource to integrate consumer-level terms
or synonyms.
• Applying natural language processing. We intend to
explore the possibility of applying natural language
processing (NLP) for both ontology learning and
knowledge retrieval. We will implement NLP
methods to facilitate automatic knowledge extraction
to expand the VISO. This will also provide intrinsic
value for applications using natural language
processing and dialogue systems.
• Intelligent mobile agents. Ontology-driven
applications could introduce the potential for
intelligent agents for learning. Realistic and engaging
agents are proven to be more effective for increasing
involvement and learning [32-35], persuasion [36],
and trustworthiness [37,38]. It provides a
cost-effective way to address patient’s concerns and
answer their questions about vaccination, which
otherwise requires healthcare professionals to
address in person. This will presumably improve the
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efficiency of healthcare delivery workflows and
reduce the cost. They also provide flexibilities for
vaccine education. Patients or parents can spend as
much time as they need with intelligent mobile
devices, and interact with intelligent devices anytime
they have access to a computer or tablet. Last but not
least, personalized agents can be automatically built
according to users’ preference to improve the
usability and acceptability of the system.
Examples like VAMATA, which is an
ontology-driven mobile application with a speech
interface designed for combat medical settings, reveal
applicable synergy between natural language
processing and ontology in mobile applications [39].
We have previously developed a proof-of-concept
ontology-driven mobile application with a natural lan-
guage interface to query a VISO knowledge-base [12]. The
ongoing evolution of VISO will assist in the continuing
development of that project.
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